Author:
Astakhova E. A.,Byazrova M. G.,Yusubalieva G. M.,Larichev V. F.,Baklaushev V. P.,Filatov A. V.
Subject
Structural Biology,Biophysics
Reference21 articles.
1. Qi H., Liu B., Wang X., Zhang L. 2022. The humoral response and antibodies against SARS-CoV-2 infection. Nat. Immunol.
23 (7), 1008‒1020. https://doi.org/10.1038/s41590-022-01248-5
2. Premkumar L., Segovia-Chumbez B., Jadi R., Martinez D.R., Raut R., Markmann A., Cornaby C., Bartelt L., Weiss S., Park Y., Edwards C.E., Weimer E., Scherer E.M., Rouphael N., Edupuganti S., Weiskopf D., Tse L.V., Hou Y.J., Margolis D., Sette A., de Silva A.M. 2020. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Sci. Immunol.
5 (48), eabc8413.
3. Cromer D., Steain M., Reynaldi A., Schlub T.E., Wheatley A.K., Juno J.A., Kent S.J., Triccas J.A., Khoury D.S., Davenport M.P. 2022. Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis. Lancet Microbe.
3 (1), e52–e61.
4. Khoury D.S., Cromer D., Reynaldi A., Schlub T.E., Wheatley A.K., Juno J.A., Subbarao K., Kent S.J., Triccas J.A., Davenport M.P. 2021. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med.
27 (7), 1205–1211.
5. Baklaushev V.P., Averyanov A.V., Sotnikova A.G., Perkina A.S., Ivanov A.V., Yusubalieva G.M., Novikova O.N., Shikina V.E., Dupik N.V., Kedrova A.G., Sanjarov A.E., Shirshova E.V., Balionis O.I., Valuev-Elliston V.T., Zakirova N.F., Glazov Ya.N., Panukhina I.A., Solov’ev N.A., Vinokurov A.G., Ivanov Yu.V., Vasiliev V.N., Klypa T.V., Troitskiy A.V. 2020. Safety and efficacy of convalescent plasma for COVID-19: the first results of a clinical study. Klin. Prakt.
11 (2), 38–50.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献